IP Library Granted Patent US 11,219,657
Granted Patent B2
US 11,219,657 · App. 16/472,088 · Granted Jan 11, 2022

Method for treating or preventing inflammation

Inventors: Romain Lecozannet (Montfavet, FR); Pascale Elizabeth Renee Fanca-Berthon (Le Thor, FR); Leila Denise Falcao (Avignon, FR); Matthieu Tenon (Avignon, FR); Antoine Charles Bily (Vedene, FR); Marc Roller (Morieres les Avignon, FR); Nicolas Feuillere (Courthezon, FR); Simona Birtic (Cavaillon, FR)
Assignee: Naturex SA
A61K36/73A23K10/30A23L33/105A61P19/02A61P29/00A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,219,657
App. No.
16/472,088
Granted
Jan 11, 2022
Kind
B2
Abstract

The present invention relates to an extract obtained from or obtainable from Rubus idaeus , a composition comprising an extract obtained from or obtainable from Rubus idaeus , processes for providing such an extract, and methods and uses relating to such extracts. In particular, the present invention relates to an extract or composition for use in treating or preventing inflammation, such as arthritis and joint inflammation.

Claims (16)

1. A method for treating or preventing inflammation comprising:

administering to a subject in need thereof a therapeutically effective amount of an extract obtained from the stems and/or the leaves of Rubus idaeus , wherein the extract is obtained using water and/or ethanol as the extraction solvent, and wherein the inflammation is associated with arthritis or joint swelling, and wherein the extract comprises:

(i) from about 1% to about 40% by weight of phenolic compounds;

(ii) from about 0.5% to about 7% by weight of hydroxycimmanic acid and ellagic compounds; and

(iii) from about 1% to about 15% by weight of flavonoid compounds.

2. The method according to claim 1 , wherein the treating or preventing inflammation reduces joint degeneration.

3. The method according to claim 1 , wherein the method reduces and/or inhibits the release of at least one proinflammatory cytokine.

4. The method according to claim 3 , wherein the at least one proinflammatory cytokine is selected from TFN-alpha, IL-6, and IL-1-beta.

5. The method according to claim 1 , wherein the method increases levels of specialised pro-resolving mediators derived from arachidonic acid, eicosapentaenoic acid and/or docosahexaenoic acid.

6. The method according to claim 1 , wherein the extract is administered in the form of a pharmaceutical or veterinary composition comprising the Rubus idaeus extract and optionally a pharmaceutically or veterinary acceptable excipient.

7. The method according to claim 6 , wherein the pharmaceutical composition is for oral, rectal, nasal, pulmonary, buccal, sublingual, transdermal, intracisternal, intraperitoneal, or parenteral administration.

8. The method according to claim 1 , wherein the extract is in the form of a food, feed or pet food composition or product, a drink product or a food, feed or pet food supplement comprising the Rubus idaeus extract and optionally food or drink acceptable ingredients.

9. The method according to claim 1 , wherein the extract is administered in an amount from about 10 mg/day to about 2000 mg/day.

10. The method according to claim 1 , wherein the subject is a human subject.

11. The method according to claim 1 , wherein the extract is obtained exclusively from the stems and/or the leaves of Rubus idaeus.

12. The method according to claim 1 , wherein the arthritis is rheumatoid arthritis and/or osteoarthritis.

Assignments (3)
CHANGE OF NAME Recorded Aug 18, 2023
From: NATUREX SA
To: GIVAUDAN FRANCE NATURALS SAS
Reel/Frame 064645/0107 →
EMPLOYMENT AGREEMENT FOR AN OBLIGATED ASSIGNOR Recorded May 6, 2021
From: FALCAO, LEILA DENISE, MRS.
To: NATUREX S.A.
Reel/Frame 056155/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2021
From: LECOZANNET, ROMAIN; FANCA-BERTHON, PASCALE ELIZABETH RENEE; TENON, MATTHIEU; BILY, ANTOINE CHARLES; ROLLER, MARC; FEUILLERE, NICOLAS; BIRTIC, SIMONA
To: NATUREX SA
Reel/Frame 056123/0065 →
Priority Claims (1)
GB 1622161 · Dec 23, 2016 · national
Continuity (1)
Related Publication 20200222486A1 · Jul 16, 2020